학술논문
Unexpected "Lazarus response" to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer
Document Type
Article
Source
In: Exploration of Targeted Anti-tumor Therapy . (Exploration of Targeted Anti-tumor Therapy, 2023, 4(5):1157-1164)
Subject
Language
English
ISSN
26923114